<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In five patients with idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, the colony-forming unit (CFU-c) assay was used to quantitate stem cells and test the possible presence of suppressor cells inhibiting bone marrow differentiation </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> five marrows failed to form CFU-c </plain></SENT>
<SENT sid="2" pm="."><plain>In one out of the five cases tested, coculture of the patient's marrow with <z:mpath ids='MPATH_458'>normal</z:mpath> marrow suppressed the latter to form CFU-c </plain></SENT>
<SENT sid="3" pm="."><plain>Removal of T-cells from the patient's bone marrow freed the <z:e sem="disease" ids="C1368107" disease_type="Disease or Syndrome" abbrv="">aplastic marrow</z:e> to produce more colonies and, in the coculture study, abrogated its inhibitory activity on the <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment of the patient with horse antihuman thymocyte globulin (ATG), improved the peripheral blood count and myelopoiesis </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the <z:e sem="disease" ids="C1368107" disease_type="Disease or Syndrome" abbrv="">aplastic marrow</z:e> increased its colony forming capacity from less than 1% pre-ATG to 46% post-ATG of the <z:mpath ids='MPATH_458'>normal</z:mpath> control, and its inhibitory activity on the <z:mpath ids='MPATH_458'>normal</z:mpath> marrow was ablated </plain></SENT>
<SENT sid="6" pm="."><plain>In selected cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, with evidence of T-suppressor cell <z:hpo ids='HP_0000752'>hyperactivity</z:hpo>, treatment with ATG may offer an alternative approach to bone-marrow transplantation </plain></SENT>
</text></document>